| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma.
|
Blood
|
2012
|
2.37
|
|
2
|
The effects of estrogen, progesterone, and C-erbB-2 receptor states on 18F-FDG uptake of primary breast cancer lesions.
|
J Nucl Med
|
2007
|
1.47
|
|
3
|
Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders.
|
Radiol Clin North Am
|
2005
|
1.40
|
|
4
|
18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer.
|
J Nucl Med
|
2004
|
1.31
|
|
5
|
Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes.
|
J Nucl Med
|
2006
|
1.28
|
|
6
|
Biodistribution and radiation dosimetry of the integrin marker 18F-RGD-K5 determined from whole-body PET/CT in monkeys and humans.
|
J Nucl Med
|
2012
|
1.18
|
|
7
|
Intense fluorodeoxyglucose activity in pulmonary amyloid lesions on positron emission tomography.
|
Clin Nucl Med
|
2003
|
1.10
|
|
8
|
18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas.
|
J Nucl Med
|
2004
|
1.08
|
|
9
|
Demonstration of excessive metabolic activity of thoracic and abdominal muscles on FDG-PET in patients with chronic obstructive pulmonary disease.
|
Clin Nucl Med
|
2005
|
1.02
|
|
10
|
F-18 FDG positron emission tomography in non-Hodgkin lymphoma of the breast.
|
Clin Nucl Med
|
2005
|
1.02
|
|
11
|
Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.00
|
|
12
|
Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation.
|
Int J Radiat Oncol Biol Phys
|
2008
|
0.95
|
|
13
|
Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression.
|
Thyroid
|
2013
|
0.93
|
|
14
|
Dual-time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity.
|
Clin Nucl Med
|
2007
|
0.92
|
|
15
|
The role of [18F]-fluorodeoxyglucose positron emission tomography in predicting plexiform neurofibroma progression.
|
J Neurooncol
|
2007
|
0.91
|
|
16
|
Biodistribution and radiation dosimetry of the hypoxia marker 18F-HX4 in monkeys and humans determined by using whole-body PET/CT.
|
Nucl Med Commun
|
2010
|
0.90
|
|
17
|
Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer.
|
Radiother Oncol
|
2012
|
0.88
|
|
18
|
Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
|
Ann Surg Oncol
|
2012
|
0.87
|
|
19
|
Detection of bone marrow metastases by FDG-PET and missed by bone scintigraphy in widespread melanoma.
|
Clin Nucl Med
|
2005
|
0.86
|
|
20
|
Evaluation of the anti-HER2 C6.5 diabody as a PET radiotracer to monitor HER2 status and predict response to trastuzumab treatment.
|
Clin Cancer Res
|
2010
|
0.84
|
|
21
|
Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers.
|
J Nucl Med
|
2013
|
0.81
|
|
22
|
Impact of expression system on the function of the C6.5 diabody PET radiotracer.
|
Tumour Biol
|
2012
|
0.81
|
|
23
|
Biodistribution and radiation dosimetry of the carbonic anhydrase IX imaging agent [(18) F]VM4-037 determined from PET/CT scans in healthy volunteers.
|
Mol Imaging Biol
|
2014
|
0.81
|
|
24
|
The effect of age, menopausal state, and breast density on (18)F-FDG uptake in normal glandular breast tissue.
|
J Nucl Med
|
2010
|
0.81
|
|
25
|
F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas.
|
Pediatr Radiol
|
2006
|
0.81
|
|
26
|
Potential role of (124)I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancer.
|
Biologics
|
2012
|
0.80
|
|
27
|
Diffuse bone marrow accumulation of FDG in a patient with chronic myeloid leukemia mimics hematopoietic cytokine-mediated FDG uptake on positron emission tomography.
|
Clin Nucl Med
|
2004
|
0.79
|
|
28
|
The role of qualitative and quantitative analysis of F18-FDG positron emission tomography in predicting pathologic response following chemoradiotherapy in patients with esophageal carcinoma.
|
J Gastrointest Cancer
|
2012
|
0.79
|
|
29
|
Inadvertent intraarterial injection of ¹⁸F-FDG: a case report and literature review of hot forearm and hot hand signs.
|
J Nucl Med Technol
|
2011
|
0.78
|
|
30
|
Sarcoidosis demonstrated by FDG PET imaging with negative findings on gallium scintigraphy.
|
Clin Nucl Med
|
2005
|
0.78
|
|
31
|
Efficacy of Tc-99m depreotide scintigraphy in the evaluation of solitary pulmonary nodules.
|
Cancer J
|
2002
|
0.77
|
|
32
|
Decreased Posttreatment SUV on PET Scan Is Associated With Improved Local Control in Medically Inoperable Esophageal Cancer.
|
Gastrointest Cancer Res
|
2011
|
0.76
|
|
33
|
Achilles tendonitis detected by FDG-PET.
|
Clin Nucl Med
|
2006
|
0.75
|
|
34
|
Preoperative FDG-PET/CT Is an Important Tool in the Management of Patients with Thick (T4) Melanoma.
|
Dermatol Res Pract
|
2012
|
0.75
|
|
35
|
An unusual site of metastasis from gastrointestinal stromal tumor.
|
Rare Tumors
|
2010
|
0.75
|
|
36
|
Increased Tc-99m MDP accumulation in soft tissue caused by bicycle riding.
|
Clin Nucl Med
|
2004
|
0.75
|
|
37
|
Solitary subcutaneous gouty nodule mimicking metastatic melanoma on FDG PET/CT.
|
Clin Nucl Med
|
2015
|
0.75
|
|
38
|
Lymphoma Causing Gastrosplenic Fistula Revealed by FDG PET/CT.
|
Clin Nucl Med
|
2017
|
0.75
|
|
39
|
Thallium-201 imaging in evaluation of Hodgkin's disease.
|
Cancer J
|
2002
|
0.75
|
|
40
|
Follow-up FDG PET in the evaluation of unexplained focal activity in the abdomen.
|
Clin Nucl Med
|
2008
|
0.75
|
|
41
|
False-positive scalp activity in 131I imaging associated with hair coloring.
|
J Nucl Med Technol
|
2013
|
0.75
|
|
42
|
Patterns of 18F-FDG PET images in patients with uncomplicated total hip arthroplasty.
|
Hell J Nucl Med
|
2015
|
0.75
|
|
43
|
Spontaneous regression of follicular, mantle cell, and diffuse large B-cell non-Hodgkin's lymphomas detected by FDG-PET imaging.
|
Clin Nucl Med
|
2004
|
0.75
|
|
44
|
Ring-shaped FDG uptake in the right lower lung: is it always a tumor?
|
Clin Nucl Med
|
2004
|
0.75
|
|
45
|
What resulted in the radioactivity superior to the left kidney on renal scintigraphy?
|
Clin Nucl Med
|
2007
|
0.75
|
|
46
|
Pelvic horseshoe kidney mimics sacral metastases on bone scan.
|
Clin Nucl Med
|
2005
|
0.75
|